KRT18 and breast carcinoma: The breast cancer cells showed mesenchymal phenotypes and the downregulation of K18 under TNF-α alone or TGF-β1/TNF-α costimulation, and, interestingly, under TGF-β1 stimulation alone there was only K18 downregulation without any changes in EMT markers (82).